Literature DB >> 8265823

Dilemmas in neuropsychiatric lupus.

J A Kovacs1, M B Urowitz, D D Gladman.   

Abstract

It is estimated that two thirds of neuropsychiatric (NP) manifestations in lupus are not directly related to active NP lupus but instead are a consequence of secondary causes such as drugs, infections, and hypertensive and metabolic complications in the setting of systemic lupus erythematosus (SLE). It is often difficult to distinguish clinically between primary central nervous system lupus and secondary causes of NP manifestations. In general, NPSLE has been reported to be a prognostic factor for a poor long-term outcome in lupus. Despite early recognition of the disease and aggressive therapeutic interventions, it is still frequently associated with increased mortality.

Entities:  

Mesh:

Year:  1993        PMID: 8265823

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  19 in total

Review 1.  Neuropsychiatric lupus.

Authors:  J G Hanly
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

2.  Detection of asymptomatic cranial neuropathies in patients with systemic lupus erythematosus and their relation to antiribosomal P antibody levels and disease activity.

Authors:  Wafaa Gaber; Yasser Ezzat; Neveen M El Fayoumy; Hanan Helmy; Abeer M Mohey
Journal:  Clin Rheumatol       Date:  2014-05-24       Impact factor: 2.980

3.  Cerebral blood flow abnormalities detected by SPECT in Behçet's-syndrome-related psychiatric disorders.

Authors:  L Mirone; L Altomonte; A Raco; M L Calcagni; V Rufini; A Zoli; M Magarò
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

4.  MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus.

Authors:  P C Sundgren; J Jennings; J T Attwood; B Nan; S Gebarski; W J McCune; Y Pang; P Maly
Journal:  Neuroradiology       Date:  2005-07-09       Impact factor: 2.804

5.  Perfusion-weighted MR imaging in cerebral lupus erythematosus.

Authors:  Page I Wang; Patricia C Cagnoli; William J McCune; Tobias Schmidt-Wilcke; Suzan E Lowe; Courtney C Graft; Stephen S Gebarski; Thomas L Chenevert; Shokoufeh Khalatbari; James D Myles; Kuanwong Watcharotone; Paul Cronin; Pia C Sundgren
Journal:  Acad Radiol       Date:  2012-05-17       Impact factor: 3.173

Review 6.  Prognosis in systemic lupus erythematosus.

Authors:  J M Esdaile
Journal:  Springer Semin Immunopathol       Date:  1994

Review 7.  Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management.

Authors:  Mariana Postal; Lilian T L Costallat; Simone Appenzeller
Journal:  CNS Drugs       Date:  2011-09-01       Impact factor: 5.749

8.  Focal transient lesions of the corpus callosum in systemic lupus erythematosus.

Authors:  Simone Appenzeller; Andreia Faria; Roberto Marini; Lilian Tereza Lavras Costallat; Fernando Cendes
Journal:  Clin Rheumatol       Date:  2006-01-11       Impact factor: 2.980

9.  Reversible dementia in systemic lupus erythematosus without antiphospholipid antibodies or cerebral infarction.

Authors:  S I Lee; H S Jeon; W H Yoo
Journal:  Rheumatol Int       Date:  2004-02-28       Impact factor: 2.631

Review 10.  Diagnosis and management of neuropsychiatric SLE.

Authors:  John G Hanly
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.